Phase 2
N=174
Mindfulness-based Cognitive Coping for ADRD Caregivers
Caregiver Stress
Bottom Line
View on ClinicalTrials.gov: NCT05979922 ↗Enrolled (actual)
174
Serious AEs
0.0%
Results posted
Jul 2025
Primary outcome: Primary: Center for Epidemiological Studies Depression Scale — 17.1; 21.98 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 2
- Interventions
- Mindfulness-based Cognitive Coping (Behavioral); Traditional Educational/Resources Program (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Photozig, Inc.
- Primary completion
- Jun 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Center for Epidemiological Studies Depression Scale |
17.1; 21.98 | — |
| PRIMARY Perceived Stress Scale |
17.12; 19.38 | — |
Summary
This project will evaluate the effectiveness of the Mindfulness-based Cognitive Coping (MCC) intervention to alleviate stress and depressive symptoms of caregivers of Individuals with Alzheimer's Disease and Related Dementia.
Eligibility Criteria
Inclusion Criteria
- Care for an individual with Alzheimer's Disease or Related Dementia (ADRD).
- Own a smartphone or tablet and have Internet access.
- Minimum age of 18 years old.
- Able to read and speak English.
- Spend at least 8 hours/week caring for a person with dementia.
- Plan to stay in the area for six months.
Exclusion Criteria
- Severe psychological or physical illness.
- Cognitive impairment or any serious medical problem that interferes with caregiving role.
- Caring for ADRD patient with a life expectancy less than six months.
- Unwillingness to participate in all aspects of the study.
Data sourced from ClinicalTrials.gov (NCT05979922). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.